Cronos Group Share Price (NASDAQ: CRON)

$2.58

▲

0.03

(1.18%)

Live

Last updated on August 27, 2025 at 11:42 pm IST

$₹

Check the interactive Cronos Group Stock chart to analyse performance

Cronos Group stock performance

as on August 27, 2025 at 11:42 pm IST

Today's Low:$2.52
Today's High:$2.59
$2.58
2.33%
Downside
Day's Volatility :2.51%
Upside
0.19%
52 Weeks Low:$1.60
52 Weeks High:$2.77
$2.58
37.98%
Downside
52 Weeks Volatility :42.24%
Upside
6.86%

Cronos Group Stock Returns

Period	Cronos Group Inc	Sector (Health Care)	Index (Russel 2000)
3 Months	25.99%	3.7%	0.0%
6 Months	37.57%	-6.9%	0.0%
1 Year	15.68%	-11.9%	0.0%
3 Years	-19.46%	7.7%	-6.9%

Cronos Group Inc Key Stats

Check Cronos Group key stats like market cap, P/E ratio, EPS, Dividend Yield, and more.

Previous Close	$2.55
Open	$2.605
Today's High	$2.585
Today's Low	$2.52
Market Capitalization	$981.4M
Today's Volume	$4.5M
52 Week High	$2.77
52 Week Low	$1.6
Revenue TTM	$130.3M
EBITDA	$-20.8M
Earnings Per Share (EPS)	$0.05
PE Ratio	51.0
Profit Margin	14.19%
Quarterly Earnings Growth YOY	0.14%
Return On Equity TTM	1.88%

Stock Returns calculator for Cronos Group Stock including INR - Dollar returns

The Cronos Group stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

Cronos Group investment value today

Current value as on today

₹1,21,946

Returns

₹21,946

(+21.95%)

Returns from Cronos Group Stock

₹17,273 (+17.27%)

Dollar Returns*

₹4,673 (+4.67%)

Indian investors sentiment towards Cronos Group Stock

21%

Period: Jul 27, 2025 to Aug 26, 2025. Change in 30 Days versus previous period

Search interest for Cronos Group Stock from India on INDmoney has increased by 21% in the last 30 days, reflecting an upward trend in search activity.

Global Institutional Holdings in Cronos Group Inc

Name
Holdings %
Name
Holdings %
Chescapmanager LLC
2.07%
Quinn Opportunity Partners LLC
1.94%
Tidal Investments LLC.
1.40%
Cannell Capital LLC
0.76%
Dimensional Fund Advisors, Inc.
0.66%
Mmcap International Inc. Spc
0.47%

Analyst Recommendation on Cronos Group Stock

Rating

Trend

Buy

61%Buy

30%Hold

7%Sell

Based on 13 Wall street analysts offering stock ratings for Cronos Group(by analysts ranked 0 to 5 stars)

Cronos Group Share Price Target

What analysts predicted

Downside of 19.07%

Target:

$2.09

Current:

$2.58

Cronos Group share price target is $2.09, a slight Downside of 19.07% compared to current price of $2.58 as per analysts' prediction.

Cronos Group Stock Insights

Price Movement
In the last 1 month, CRON stock has moved up by 24.1%
Increasing Revenue
Revenue is up for the last 3 quarters, 30.30M → 44.25M (in $), with an average increase of 16.6% per quarter
Decreasing Net Profit
Netprofit is down for the last 3 quarters, 43.72M → -40.36M (in $), with an average decrease of 422.7% per quarter
CRON vs HLN (3 yr)
In the last 3 years, Haleon Plc Spon Ads has given 54.5% return, outperforming this stock by 73.2%

Cronos Group Inc Financials

Revenue

Profit

Cash Flow

Annually

Quarterly

FY19

FY20

FY21

FY22

FY23

FY24

	FY19	Y/Y Change
Revenue	$23.8M	↑ 95.94%
Net Income	$1.2B	↓ 5487.2%
Net Profit Margin	4.9K%	↑ 5086.18%

	FY20	Y/Y Change
Revenue	$46.7M	↑ 96.71%
Net Income	$-74.6M	↓ 106.4%
Net Profit Margin	-159.72%	↓ 5067.4%

	FY21	Y/Y Change
Revenue	$74.4M	↑ 59.32%
Net Income	$-396.7M	↑ 431.63%
Net Profit Margin	-532.95%	↓ 373.23%

	FY22	Y/Y Change
Revenue	$91.9M	↑ 23.47%
Net Income	$-168.7M	↓ 57.47%
Net Profit Margin	-183.6%	↑ 349.35%

	FY23	Y/Y Change
Revenue	$87.2M	↓ 5.07%
Net Income	$-74.0M	↓ 56.17%
Net Profit Margin	-84.78%	↑ 98.82%

	FY24	Y/Y Change
Revenue	$161.8M	↑ 85.49%
Net Income	$41.1M	↓ 155.54%
Net Profit Margin	25.39%	↑ 110.17%

Q1 FY24

Q2 FY24

Q3 FY24

Q4 FY24

Q1 FY25

Q2 FY25

	Q1 FY24	Q/Q Change
Revenue	$25.2M	↑ 2.44%
Net Income	$-2.2M	↓ 94.99%
Net Profit Margin	-8.9%	↑ 172.99%

	Q2 FY24	Q/Q Change
Revenue	$27.8M	↑ 10.25%
Net Income	$-8.8M	↑ 290.76%
Net Profit Margin	-31.55%	↓ 22.65%

	Q3 FY24	Q/Q Change
Revenue	$34.3M	↑ 23.45%
Net Income	$8.3M	↓ 195.34%
Net Profit Margin	24.37%	↑ 55.92%

	Q4 FY24	Q/Q Change
Revenue	$30.3M	↓ 11.57%
Net Income	$43.7M	↑ 423.76%
Net Profit Margin	144.32%	↑ 119.95%

	Q1 FY25	Q/Q Change
Revenue	$32.3M	↑ 6.47%
Net Income	$6.1M	↓ 86.0%
Net Profit Margin	18.98%	↓ 125.34%

	Q2 FY25	Q/Q Change
Revenue	$44.3M	↑ 37.16%
Net Income	$-40.4M	↓ 759.35%
Net Profit Margin	-91.22%	↓ 110.2%

FY19

FY20

FY21

FY22

FY23

FY24

	FY19	Y/Y Change
Profit	$-17.6M	↓ 383.23%

	FY20	Y/Y Change
Profit	$-25.8M	↑ 46.8%

	FY21	Y/Y Change
Profit	$-17.5M	↓ 32.13%

	FY22	Y/Y Change
Profit	$15.4M	↓ 188.03%

	FY23	Y/Y Change
Profit	$11.9M	↓ 22.85%

	FY24	Y/Y Change
Profit	$25.2M	↑ 111.59%

Q1 FY24

Q2 FY24

Q3 FY24

Q4 FY24

Q1 FY25

Q2 FY25

	Q1 FY24	Q/Q Change
Profit	$4.5M	↑ 134.34%

	Q2 FY24	Q/Q Change
Profit	$5.3M	↑ 17.78%

	Q3 FY24	Q/Q Change
Profit	$3.6M	↓ 31.61%

	Q4 FY24	Q/Q Change
Profit	$10.8M	↑ 199.28%

	Q1 FY25	Q/Q Change
Profit	$13.7M	↑ 27.08%

	Q2 FY25	Q/Q Change
Profit	$14.5M	↑ 5.61%

FY19

FY20

FY21

FY22

FY23

FY24

	FY19	Y/Y Change
Operating Cash Flow	$-130.0M	↑ 1718.19%
Investing Cash Flow	$-603.5M	↑ 576.71%
Financing Cash Flow	$1.9B	↑ 1535.55%

	FY20	Y/Y Change
Operating Cash Flow	$-142.5M	↑ 9.58%
Investing Cash Flow	$20.2M	↓ 103.34%
Financing Cash Flow	$-5.5M	↓ 100.29%

	FY21	Y/Y Change
Operating Cash Flow	$-153.6M	↑ 7.83%
Investing Cash Flow	$-28.9M	↓ 243.41%
Financing Cash Flow	$-13.4M	↑ 145.97%

	FY22	Y/Y Change
Operating Cash Flow	$-88.9M	↓ 42.1%
Investing Cash Flow	$-1.8M	↓ 93.63%
Financing Cash Flow	$-2.9M	↓ 78.45%

	FY23	Y/Y Change
Operating Cash Flow	$-42.8M	↓ 51.84%
Investing Cash Flow	$-59.5M	↑ 3130.13%
Financing Cash Flow	$-1.0M	↓ 64.45%

	FY24	Y/Y Change
Operating Cash Flow	$18.8M	↓ 143.99%
Investing Cash Flow	$175.1M	↓ 394.37%
Financing Cash Flow	$-1.2M	↑ 19.51%

Q1 FY24

Q2 FY24

Q3 FY24

Q4 FY24

Q1 FY25

Q2 FY25

	Q1 FY24	Q/Q Change
Operating Cash Flow	$-2.2M	↓ 112.91%
Investing Cash Flow	$188.7M	↑ 127.09%
Financing Cash Flow	$-642.1K	↑ 194.55%

	Q2 FY24	Q/Q Change
Operating Cash Flow	$1.7M	↓ 178.17%
Investing Cash Flow	$-7.1M	↓ 103.77%
Financing Cash Flow	$-260.0K	↓ 59.51%

	Q3 FY24	Q/Q Change
Operating Cash Flow	$11.6M	↑ 575.31%
Investing Cash Flow	$-818.0K	↓ 88.5%
Financing Cash Flow	$-13.0K	↓ 95.0%

	Q4 FY24	Q/Q Change
Operating Cash Flow	$7.7M	↓ 33.35%
Investing Cash Flow	$-5.0M	↑ 515.16%
Financing Cash Flow	$-313.0K	↑ 2307.69%

	Q1 FY25	Q/Q Change
Operating Cash Flow	$-2.1M	↓ 127.15%
Investing Cash Flow	$-55.4M	↑ 1000.08%
Financing Cash Flow	$-2.9M	↑ 836.1%

	Q2 FY25	Q/Q Change
Operating Cash Flow	$3.0M	↓ 241.04%
Investing Cash Flow	$26.1K	↓ 100.05%
Financing Cash Flow	$-7.9M	↑ 169.63%

Cronos Group Technicals Summary

Sell

Neutral

Buy

Cronos Group is currently in a neutral trading position according to technical analysis indicators.

Cronos Group Inc Vs Peers

Returns

Ratio's

Overview

Company Name	1 Month	6 Month	1 Year	3 Years	5 Years
Cronos Group Inc	23.54%	37.57%	15.68%	-19.46%	-55.11%
Haleon Plc Spon Ads	-0.77%	-5.64%	-3.46%	58.57%	29.89%
United Therapeutics Corporation	3.75%	-3.0%	-11.43%	42.23%	73.96%
Zoetis Inc.	2.71%	-6.16%	-14.98%	-1.93%	-3.23%
Neurocrine Biosciences Inc.	2.39%	16.43%	-10.25%	29.99%	19.76%

Company Name	P/E Ratio	P/B Ratio	PEG Ratio	EPS	ROE	ROA	Div Yield	BVPS
Cronos Group Inc	51.0	51.0	NA	-0.01	0.02	-0.02	NA	2.82
Haleon Plc Spon Ads	21.51	21.51	3.13	0.49	0.09	0.05	0.01	1.77
United Therapeutics Corporation	12.07	12.07	1.43	26.59	0.19	0.13	NA	158.65
Zoetis Inc.	26.69	26.69	2.51	6.33	0.53	0.15	0.01	11.21
Neurocrine Biosciences Inc.	40.49	40.49	0.27	6.74	0.13	0.09	NA	27.22

Company Name	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin
Cronos Group Inc	Buy	$981.4M	-55.11%	51.0	14.19%
Haleon Plc Spon Ads	Buy	$43.9B	29.89%	21.51	13.81%
United Therapeutics Corporation	Buy	$14.0B	73.96%	12.07	40.36%
Zoetis Inc.	Buy	$68.6B	-3.23%	26.69	27.83%
Neurocrine Biosciences Inc.	Buy	$13.6B	19.76%	40.49	13.88%

About Cronos Group Inc

Cronos Group Inc., a cannabinoid company, engages in the cultivation, production, distribution, and marketing of cannabis products in Canada, Israel, and internationally. It offers dried flowers, pre-rolls, oils, vaporizers, edibles, and cannabis tinctures under the Spinach, Lord Jones, and PEACE NATURALS brand names. The company is based in Stayner, Canada.

Organization	Cronos Group
Employees	459
CEO	Mr. Michael Ryan Gorenstein J.D.
Industry	Health Technology

Key Management of Cronos Group Inc

Name	Title
Mr. Michael Ryan Gorenstein J.D.	President, CEO & Chairman
Ms. Anna Shlimak	Chief Financial Officer
Ms. Shannon Buggy	Senior VP, Global Head of People & Technology
Mr. Jeffrey David Jacobson	Chief Growth Officer
Mr. James Holm	Executive Officer
Mr. Lloyd Wilson	Principal Accounting Officer, VP & Controller
Mr. Terry Gregory-Joseph Doucet	General Counsel & Corporate Secretary
Mr. Arye Weigensberg	Senior VP and Head of Research & Development
Mr. Adam Wagner	Senior VP & Head of Cronos Israel

Important FAQs about investing in CRON Stock from India :

What is Cronos Group share price today?

Cronos Group share price today is $2.58 as on August 27, 2025 at 11:42 pm IST. Cronos Group share today touched a day high of $2.59 and a low of $2.52.

What is the 52 week high and 52 week low for Cronos Group share?

Cronos Group share touched a 52 week high of $2.77 and a 52 week low of $1.60. Cronos Group stock price today i.e. August 27, 2025 at 11:42 pm IST is trending at $2.58, lower by 6.86% versus the 52 week high.

How to invest in Cronos Group Stock (CRON) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for Cronos Group on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Cronos Group Shares that will get you 0.5814 shares as per Cronos Group share price of $2.58 per share as on August 27, 2025 at 11:42 pm IST.

What is the minimum amount required to buy Cronos Group Stock (CRON) from India?

Indian investors can start investing in Cronos Group (CRON) shares with as little as ₹87.86 or $1 (as of August 27, 2025) using the INDmoney app.
For example: If you want to invest $10 or ₹878.60 in Cronos Group stock (as per the Rupee-Dollar exchange rate as on August 27, 2025). Based on Cronos Group share’s latest price of $2.58 as on August 27, 2025 at 11:42 pm IST, you will get 3.8760 shares of Cronos Group. Learn more about fractional shares .

What are the returns that Cronos Group has given to Indian investors in the last 5 years?

Cronos Group stock has given -55.11% share price returns and 18.89% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?